Rehan Raina: Did You Know Your Immune Cells are What Actually Kill Cancer?
Rehan Raina, Quality and Marketing Manager at Salalah Macaroni Co SAOC, shared a post on LinkedIn about recent articles, adding։
“Did you know your immune cells are what actually kill cancer?
As a surgeon who removed hundreds of cancers, this is something I lived firsthand and it took me years to fully reckon with it.
When an oncologist orders a CBC, they are looking at red blood cells for anemia, platelets to prevent bleeding, and neutrophils to avoid infection.
All valid. All important for managing treatment side effects.
But none of those cells kill cancer.
The cells that kill cancer are your natural killer cells and T cells.
They live inside that same CBC under the lymphocyte count.
And for decades, most oncologists never looked at them.
Not out of negligence, but because there was no drug or intervention that could meaningfully increase them.
So the number sat there, ignored.
That is changing now in a significant way.
Researchers have developed a way to extract a patient’s own T cells, engineer them in a lab to recognize and attack cancer cells specifically, and reinfuse them back into the body.
This is called CAR-T cell therapy, and it is already producing outcomes in certain blood cancers that conventional treatment never achieved.
The broader lesson here is one I think about constantly.
Your immune system is your first and most powerful defense against cancer.
The lifestyle choices that protect and strengthen it, sleep, nutrition, stress management, and movement, are not soft wellness advice.
They are oncology.”
Title: Cancer immunotherapy using checkpoint blockade
Authors: Antoni Ribas, Jedd D Wolchok

Title: The future of immune checkpoint therapy
Authors: Padmanee Sharma, James P Allison

Title: NK cells for cancer immunotherapy
Authors: Noriko Shimasaki, Amit Jain, Dario Campana

Title: Treatment of the “syndrome of doubles”
Authors: G N Christodoulou

Proceed to the video attached to the post.
Stay updated on all scientific advances Hemostasis Today.
-
Nov 15, 2026, 04:31Aakriti Gupta: Anticoagulation for Leaflet Thickening After TAVR
-
Nov 14, 2026, 23:57Jamie S. Y. Ho: Exploring the Mechanisms of Arterial Thrombosis and the Evolution of Antithrombotic Therapy
-
Nov 14, 2026, 23:53Jacopo Imberti: The Past, Present and Future of Arterial Thrombosis Research
-
Nov 14, 2026, 23:48Shrouk Ramadan: Joining the Editorial Review Board of Clinical and Applied Thrombosis and Hemostasis
-
Nov 14, 2026, 23:46Habib Bennaceur: Moving Towards Fewer Limitations for People Living With Haemophilia
-
Nov 14, 2026, 23:44Paul Healy: EU Approves Frehemgo for Haemophilia A
-
Nov 14, 2026, 23:43Mehak Trehan: ASH 2026 Benign Hematology – Ten Abstracts Through an Indian Lens
-
Nov 14, 2026, 23:33Felipe Magalhaes Furtado: Artificial Intelligence Advances PNH Clone Detection Through Machine Learning
-
Nov 14, 2026, 23:33Mona Alfaraj: International Pathology Day Promotes Education in Hemoglobinopathy Diagnostics